NA. V.I.KULAKOV»
FSBI «National Medical Research Center for Obstetrics, Gynecology
and Perinatology named after Academician V.I.Kulakov»
Ministry of Health of the Russian Federation
FSBI «National Medical
Research Center for Obstetrics, Gynecology
and Perinatology named after Academician V.I.Kulakov»
Ministry of Health of the Russian Federation
Department of Gynecological Endocrinology
Department of Gynecological Endocrinology
Head of the Department: Antonina Smetnik, PhD
E-mail: a_smetnik@oparina4.ru
The patients of the Department are women from 18 years old up to postmenopausal period.
Highly qualified and experienced specialists applying the most advanced tools carry out unique multidisciplinary diagnostics and make individual therapy program for each patient, such as medical and physiotherapeutic procedures, depending on the medical situation, age and general health condition of a woman.
The main goal of the team of the Department is restoration of the patients’ health and quality of life, quick and comfortable adaptation to therapy, if a long-term or permanent supportive treatment is recommended.
FOCUS AREA
- Reproductive health care
- Timely diagnosis, prevention and treatment of early and late systemic changes in endocrine disorders
- Prevention of oncological diseases
DIAGNOSTICS OF ENDOCRINE AND GYNECOLOGIC DISEASES
The resources in the Department allow to carry out comprehensive examination, including diagnostics of molecular genetic, metabolic and endocrinological processes, underlying hormone-associated diseases of the reproductive system. Various algorithms for examining the patients with menstrual disorder and treatment are applied to women with spontaneous and surgical menopause in peri- and postmenopausal periods.
METHODS OF TREATMENT FOR ENDOCRINE AND GYNECOLOGIC DISEASES
- Individual and differentiated therapy programs based on the diagnosed disease, systemic disorders, the results of diagnostic tests, the woman's age, reproductive capability and personal desires regarding pregnancy planning
- Hormonal and non-hormonal drugs in therapy and prevention of the diseases
-
The best world practices of effective and safe therapeutic programs, as well as the unique clinical developments are used in the Department. Therapy can be adjusted during treatment, depending on the woman's individual response to therapy and the effectiveness of treatment.
Currently, the criteria for early prediction of the possibility of the development of premature ovarian failure and timely prevention measures aimed at fertility preservation have been developed.
- Modern methods of therapy for benign tumors of the uterus and ovaries allowing to avoid radical surgery
- Innovative methods for the diagnosis and treatment of recurrent hyperplastic processes of the endometrium and myometrium
- Prognostic models of the risk of endometrial cancer and new approaches to patient management
- Treatment of urogenital disorders based on the use of modern instrumental diagnostic methods, including urodynamic studies (UDS)
- Individual selection of drugs, training the pelvic floor muscles, selection of physiotherapeutic methods and minimally invasive treatment for urinary incontinence
- Dual-energy x-ray absorptiometry/densitometry to diagnose and monitor treatment of osteoporosis and to assess the markers for bone remodeling
ENDOCRINE AND GYNECOLOGIC DISEASES
The Department provides management of the following conditions:
- different causes of infertility: endocrine, tubal-peritoneal, uterine and male infertility;
- intrauterine synechiae;
- hyperandrogenism;
- hyperprolactinemia;
- climacteric syndrome and associated emotional and vegetative-vascular disorders;
- vaginal bleeding;
- concomitant endocrine pathology (thyroid and adrenal dysfunction, diabetes mellitus, hypothalamic and pituitary tumors, low body weight, obesity);
- osteoporosis;
- primary and secondary amenorrhea;
- primary and secondary dysmenorrhea;
- primary and secondary oligomenorrhea;
- preparation of women with a burdened obstetric and gynecological history to pregnancy;
- premenstrual syndrome;
- primary ovarian insufficiency (POI);
- endometrial hyperplasia and polyps;
- rehabilitation of women who have undergone treatment for cancer;
- polycystic ovary syndrome;
- pelvic pain syndrome;
- urogenital atrophy – vaginal dryness and burning sensation;
- urogenital disorders;
- chronic endometritis;
- endometriosis of various localization